CA
AGN

Calton & Associates’s Allergan plc AGN Stock Holding History

Calton & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-24,338
Closed -$4.31M – 363
2020
Q1 		$4.31M Buy
24,338
+9,162
+60% +$1.73M 1.07% 15
2019
Q4 		$2.9M Sell
15,176
-292
-2% -$52.7K 0.58% 31
2019
Q3 		$2.6M Sell
15,468
-205
-1% -$33.4K 0.58% 28
2019
Q2 		$2.62M Sell
15,673
-862
-5% -$119K 0.74% 22
2019
Q1 		$2.42M Sell
16,535
-565
-3% -$81.9K 0.74% 21
2018
Q4 		$2.29M Sell
17,100
-2,988
-15% -$490K 0.84% 20
2018
Q3 		$3.83M Sell
20,088
-214
-1% -$39.3K 1.13% 11
2018
Q2 		$3.75M Buy
20,302
+29
+0.1% +$4.66K 1.09% 12
2018
Q1 		$3.41M Sell
20,273
-96
-0.5% -$16.1K 0.99% 14
2017
Q4 		$3.83M Buy
+20,369
New +$3.66M 0.96% 13

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Calton & Associates's AGN Position: Q2 2020 in Review

Calton & Associates sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 24,338 shares — an estimated $4.31M sold.

Calton & Associates first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $4.31M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Calton & Associates reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Calton & Associates sold 24,338 Allergan plc shares in Q2 2020, an estimated $4.31M.
  • Calton & Associates first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • Calton & Associates's Allergan plc position peaked at $4.31M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Calton & Associates's 13F filing for Q2 2020, filed 10 Aug 2020.